Abstract: Cytomegalovirus (CMV) is the most important viral agent in kidney transplantation. Clinical manifestations of CMV disease in transplantation include hepatitis, pneumonitis, pancreatitis, kidney allograft dysfunction, colitis, and meningoencephalitis. However, skin involvement is rare. We describe a severely compromised cadaveric-kidney transplant recipient who developed renal failure, colonic ulcers, and a maculopapular rash accompanied by fever and malaise 4 months after transplantation. Only the skin biopsy was diagnostic and consistent with CMV disease. Intravenous ganciclovir administration resulted in clinical improvement of CMV-induced skin lesions; kidney function normalized and the patient became asymptomatic after 14 days of ganciclovir therapy. Nephrologists should consider the diagnosis of CMV disease in the febrile immunosuppressed patient with skin involvement. Skin biopsy must be considered as a useful and safe procedure in patients with a rash to obtain a prompt diagnosis and efficiently treat this immunocompromised population.
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Cytomegalovirus (CMV) infection occurs mainly after the first month of solid-organ transplantation, with an estimated incidence of 30-50%, depending on the serologic status of both donor and recipient and the type of transplanted organ. Exposure to the virus increases with age in the general population, and virus is present in more than 65% of donors and recipients at the time of transplantation. Moreover, the concurrent administration of immunosuppressants further raises the risk of clinically relevant CMV disease (1-3). It has been estimated that in renal transplant recipients 20% of graft failures, 30% of febrile episodes, 35% of leukopenic episodes, and 25% of deaths are caused by CMV (4). As in this case report, seropositive recipients of CMV-positive kidneys are at risk for both reactivation of latent virus and superinfection with a new viral strain, despite adequate viral prophylaxis.
CMV infection is usually defined as the documentation of viral replication, and can be symptomatic or asymptomatic. CMV overt infection (called CMV disease) can present as a mild disease with On admission the patient was dehydrated, hypotensive, and febrile; he was on methylprednisone 10 mg/day, mycophenolate mofetil 3 g/day, cyclosporine 200 mg/day, and diltiazem 300 mg/day. Cyclosporine trough levels varied between 250 and 300 ng/dl, and intravenous fluids were administered. A kidney biopsy was consistent with acute tubular necrosis. Due to long-standing and serious diarrhea, a colonoscopy was performed and disclosed numerous colonic ulcers, which were randomly biopsied but were non-diagnostic (CMV early antigen and immune-staining were negative). Myco- phenolate was reduced to 2 g/day, the cyclosporine dose was diminished to 100 mg/day, and diltiazem was discontinued. Blood, urine, and stool cultures and toxin tests for Clostridium difficile were repeatedly negative. Tuberculosis and fungal serologic tests and serum chemistries were non-contributory. An abdominal ultrasound and computed tomography scan of the thorax were within normal limits. Viremia and antigen pp65 tests for CMV (performed four times during hospitalization) were also negative. Fundoscopic examination was unremarkable, except for grade one hypertensive retinopathy.
Three days after hydration, his renal function improved. The patient remained febrile (39 aeC on average), anorectic, and with copious amounts of mucous and bloody stools. Mycophenolate was reduced to 1 g/day. Ten days after admission he developed a maculopapular rash that was predominantly distributed over the trunk ( Fig. 1) . A skin biopsy was consistent with CMV infection, disclosing cytomegalic cells with large intranuclear inclusions surrounded by a clear halo in dermal endothelial cells ( Fig. 2A) , later confirmed by immunohistochemistry (Fig. 2B) . He was started on a 14-day course of intravenous ganciclovir.
By the eighth day of antiviral therapy the skin lesions resolved, and 3 days later his diarrhea disappeared. His basic immunosuppression regimen was reinstituted; he became afebrile one day before discontinuation of ganciclovir and was subsequently discharged. Four months after discharge, the patient is asymptomatic with normal renal function. In our patient, the maculopapular rash appeared 10 days after the onset of persistent fever, superimposed on steroid-and cyclosporine-induced acne. It was non-pruriginous, non-confluent, and distributed over the trunk, predominantly in the neck area. The time of onset, the characteristics of the rash, and the clinical picture led to the suspicion that the maculopapular eruption was CMVrelated. The skin biopsy proved to be a rapid, safe, and efficient method to obtain a prompt diagnosis and therefore hastened appropriate treatment.
Regarding the colonic ulcers, we believe they were CMV-related despite the fact that immunohistochemistry studies failed to confirm our clinical impression, as the diarrhea resolved after ganciclovir administration. Acute tubular necrosis was attributed to dehydration, and cyclosporine could have played an additional role.
The immunosuppressed patient with fever and rash can present a challenging clinical problem. Physicians caring for transplant patients must be aware of the possibility of disseminated CMV disease when fever is accompanied by a generalized, nonspecific rash or skin ulcerations. The rarity of CMV skin involvement may be due to underdiagnosis, as nonspecific skin lesions are frequently overlooked. Skin biopsy may document the disease before cultural or serologic confirmation is available, and an early diagnosis and specific treatment may consequently reduce the mortality of this potentially fatal infection.
